FF:10705-109H3: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 69: | Line 69: | ||
|sample_ethnicity=C | |sample_ethnicity=C | ||
|sample_experimental_condition= | |sample_experimental_condition= | ||
|sample_gostat=GO:0044464;cell part;0!GO:0005622;intracellular;0!GO:0044424;intracellular part;4.2010501955785e-220!GO:0005737;cytoplasm;1.354189572724e-174!GO:0043226;organelle;1.21635020966274e-146!GO:0043229;intracellular organelle;2.82132356370335e-146!GO:0043231;intracellular membrane-bound organelle;3.6339308365238e-141!GO:0043227;membrane-bound organelle;5.72147349708684e-141!GO:0044444;cytoplasmic part;3.17843223790567e-127!GO:0044422;organelle part;2.32268221672492e-105!GO:0044446;intracellular organelle part;5.42756937399758e-104!GO:0032991;macromolecular complex;4.80178101973746e-80!GO:0005515;protein binding;1.36687273764235e-76!GO:0044238;primary metabolic process;2.62641136742205e-69!GO:0044237;cellular metabolic process;8.4392735594903e-68!GO:0043170;macromolecule metabolic process;6.92295235684495e-66!GO:0030529;ribonucleoprotein complex;2.39104642007039e-65!GO:0005739;mitochondrion;6.05145633784348e-55!GO:0043233;organelle lumen;4.65826328347897e-53!GO:0031974;membrane-enclosed lumen;4.65826328347897e-53!GO:0019538;protein metabolic process;3.58932878218364e-51!GO:0003723;RNA binding;1.4658414275815e-47!GO:0031090;organelle membrane;7.81680103724962e-47!GO:0044260;cellular macromolecule metabolic process;3.15235120007032e-46!GO:0044428;nuclear part;1.74193088197055e-45!GO:0044267;cellular protein metabolic process;7.34228777047862e-45!GO:0005634;nucleus;4.35650640977816e-42!GO:0005840;ribosome;7.54091720739777e-42!GO:0043234;protein complex;9.55976594593365e-42!GO:0015031;protein transport;1.52988270290756e-41!GO:0006412;translation;3.75365511851366e-41!GO:0016043;cellular component organization and biogenesis;6.8883012429416e-41!GO:0033036;macromolecule localization;1.97661624832904e-40!GO:0045184;establishment of protein localization;2.15670263703391e-38!GO:0008104;protein localization;6.23426180949595e-38!GO:0003735;structural constituent of ribosome;1.92332259521131e-37!GO:0044429;mitochondrial part;2.67069046945008e-37!GO:0009058;biosynthetic process;5.7501346988603e-35!GO:0005829;cytosol;1.32896081314533e-34!GO:0009059;macromolecule biosynthetic process;1.86180080380695e-34!GO:0033279;ribosomal subunit;1.77072030127202e-33!GO:0046907;intracellular transport;1.36556302705589e-32!GO:0006396;RNA processing;5.29683063956063e-32!GO:0043283;biopolymer metabolic process;2.36544414942804e-31!GO:0044249;cellular biosynthetic process;2.80410771243746e-31!GO:0031967;organelle envelope;3.57513868348879e-31!GO:0031975;envelope;7.51400439759397e-31!GO:0031981;nuclear lumen;4.58992378177162e-29!GO:0010467;gene expression;1.01710354910321e-28!GO:0016071;mRNA metabolic process;1.41584950002716e-27!GO:0006886;intracellular protein transport;2.33601976163346e-27!GO:0008380;RNA splicing;4.69791906717595e-25!GO:0005830;cytosolic ribosome (sensu Eukaryota);8.84862283651527e-25!GO:0005740;mitochondrial envelope;9.07524986063509e-25!GO:0006397;mRNA processing;6.87109307263335e-24!GO:0031966;mitochondrial membrane;1.8035991073078e-23!GO:0065003;macromolecular complex assembly;2.74573000316279e-23!GO:0019866;organelle inner membrane;5.02404772148256e-23!GO:0005783;endoplasmic reticulum;4.01958383769302e-22!GO:0005743;mitochondrial inner membrane;1.04883999119342e-21!GO:0006139;nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;1.76019074603624e-21!GO:0022607;cellular component assembly;1.95173967255757e-21!GO:0006996;organelle organization and biogenesis;2.63060722374312e-21!GO:0006119;oxidative phosphorylation;1.0096339487278e-20!GO:0022613;ribonucleoprotein complex biogenesis and assembly;1.09284166971322e-20!GO:0043228;non-membrane-bound organelle;5.10128328008145e-20!GO:0043232;intracellular non-membrane-bound organelle;5.10128328008145e-20!GO:0051641;cellular localization;7.83155626801186e-20!GO:0006457;protein folding;9.35029478239621e-20!GO:0051649;establishment of cellular localization;9.68684288286291e-20!GO:0044455;mitochondrial membrane part;1.42756955012583e-19!GO:0044445;cytosolic part;1.74000077215365e-19!GO:0012505;endomembrane system;2.07398756422481e-19!GO:0005654;nucleoplasm;4.20716976357011e-19!GO:0005794;Golgi apparatus;2.19237076878764e-18!GO:0005681;spliceosome;6.04021356478995e-18!GO:0015934;large ribosomal subunit;7.35304830800398e-18!GO:0048770;pigment granule;2.30342503748866e-17!GO:0042470;melanosome;2.30342503748866e-17!GO:0044432;endoplasmic reticulum part;4.84388263265566e-17!GO:0015935;small ribosomal subunit;1.45164237932674e-16!GO:0044451;nucleoplasm part;2.30521351310397e-16!GO:0005746;mitochondrial respiratory chain;2.49612649753888e-16!GO:0048193;Golgi vesicle transport;4.15508353981953e-16!GO:0006512;ubiquitin cycle;5.17318271521887e-16!GO:0008134;transcription factor binding;5.40991501435214e-16!GO:0016874;ligase activity;9.59487674506801e-16!GO:0017111;nucleoside-triphosphatase activity;2.49812343120706e-15!GO:0016462;pyrophosphatase activity;2.92406513797872e-15!GO:0016818;hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides;3.06234903741495e-15!GO:0022618;protein-RNA complex assembly;3.18573761165711e-15!GO:0051603;proteolysis involved in cellular protein catabolic process;4.33916984082767e-15!GO:0016817;hydrolase activity, acting on acid anhydrides;4.35812426794924e-15!GO:0031980;mitochondrial lumen;9.25833355289726e-15!GO:0005759;mitochondrial matrix;9.25833355289726e-15!GO:0019941;modification-dependent protein catabolic process;9.28932094271442e-15!GO:0043632;modification-dependent macromolecule catabolic process;9.28932094271442e-15!GO:0016655;oxidoreductase activity, acting on NADH or NADPH, quinone or similar compound as acceptor;9.39387578308222e-15!GO:0044257;cellular protein catabolic process;9.49771673880088e-15!GO:0000166;nucleotide binding;1.3144023822607e-14!GO:0006511;ubiquitin-dependent protein catabolic process;1.50867278660339e-14!GO:0006605;protein targeting;1.58552106126626e-14!GO:0044265;cellular macromolecule catabolic process;1.80948882300496e-14!GO:0000502;proteasome complex (sensu Eukaryota);2.60470108253103e-14!GO:0050136;NADH dehydrogenase (quinone) activity;3.06069378219338e-14!GO:0003954;NADH dehydrogenase activity;3.06069378219338e-14!GO:0008137;NADH dehydrogenase (ubiquinone) activity;3.06069378219338e-14!GO:0051082;unfolded protein binding;5.35062846745436e-14!GO:0043285;biopolymer catabolic process;5.75898560440767e-14!GO:0016192;vesicle-mediated transport;8.61682337923966e-14!GO:0043412;biopolymer modification;8.62146782269803e-14!GO:0008135;translation factor activity, nucleic acid binding;4.09845827401509e-13!GO:0030163;protein catabolic process;5.54697378451802e-13!GO:0005842;cytosolic large ribosomal subunit (sensu Eukaryota);7.07634526196162e-13!GO:0009057;macromolecule catabolic process;8.88725847910073e-13!GO:0006464;protein modification process;1.26759694422671e-12!GO:0005793;ER-Golgi intermediate compartment;1.68188114855704e-12!GO:0042775;organelle ATP synthesis coupled electron transport;2.12491321395128e-12!GO:0042773;ATP synthesis coupled electron transport;2.12491321395128e-12!GO:0030964;NADH dehydrogenase complex (quinone);2.12491321395128e-12!GO:0045271;respiratory chain complex I;2.12491321395128e-12!GO:0005747;mitochondrial respiratory chain complex I;2.12491321395128e-12!GO:0051186;cofactor metabolic process;2.38475567349756e-12!GO:0016651;oxidoreductase activity, acting on NADH or NADPH;2.41368340319742e-12!GO:0005843;cytosolic small ribosomal subunit (sensu Eukaryota);3.1676381443921e-12!GO:0005761;mitochondrial ribosome;3.94377692176607e-12!GO:0000313;organellar ribosome;3.94377692176607e-12!GO:0006120;mitochondrial electron transport, NADH to ubiquinone;6.62992480277732e-12!GO:0042175;nuclear envelope-endoplasmic reticulum network;9.20573142976423e-12!GO:0006259;DNA metabolic process;2.34288960516556e-11!GO:0005789;endoplasmic reticulum membrane;3.19147729191622e-11!GO:0016070;RNA metabolic process;4.16651733910135e-11!GO:0044248;cellular catabolic process;4.71764388966702e-11!GO:0003712;transcription cofactor activity;7.77919636808241e-11!GO:0012501;programmed cell death;1.13907624638549e-10!GO:0032553;ribonucleotide binding;1.16809842047913e-10!GO:0032555;purine ribonucleotide binding;1.16809842047913e-10!GO:0005730;nucleolus;1.21805287749335e-10!GO:0048523;negative regulation of cellular process;1.33301803304463e-10!GO:0043687;post-translational protein modification;1.79650193927727e-10!GO:0006915;apoptosis;1.93465764197554e-10!GO:0003676;nucleic acid binding;2.60500046367607e-10!GO:0017076;purine nucleotide binding;2.6940825462848e-10!GO:0008639;small protein conjugating enzyme activity;4.70699201159277e-10!GO:0003743;translation initiation factor activity;4.93524108763239e-10!GO:0009055;electron carrier activity;6.15215044566572e-10!GO:0019787;small conjugating protein ligase activity;6.27083758070963e-10!GO:0006732;coenzyme metabolic process;7.74171344490073e-10!GO:0004842;ubiquitin-protein ligase activity;8.93822613918186e-10!GO:0006413;translational initiation;1.28829016546304e-09!GO:0008219;cell death;1.42910071656671e-09!GO:0016265;death;1.42910071656671e-09!GO:0000398;nuclear mRNA splicing, via spliceosome;1.80164646162984e-09!GO:0000375;RNA splicing, via transesterification reactions;1.80164646162984e-09!GO:0000377;RNA splicing, via transesterification reactions with bulged adenosine as nucleophile;1.80164646162984e-09!GO:0008565;protein transporter activity;2.64017968471543e-09!GO:0009259;ribonucleotide metabolic process;3.2497402071932e-09!GO:0006446;regulation of translational initiation;5.342480666427e-09!GO:0006913;nucleocytoplasmic transport;5.342480666427e-09!GO:0046961;hydrogen ion transporting ATPase activity, rotational mechanism;6.03509698333961e-09!GO:0016879;ligase activity, forming carbon-nitrogen bonds;7.169471722159e-09!GO:0048519;negative regulation of biological process;8.60329125408353e-09!GO:0044431;Golgi apparatus part;8.61342024712554e-09!GO:0051169;nuclear transport;9.1276954516634e-09!GO:0009150;purine ribonucleotide metabolic process;9.34571589047558e-09!GO:0030120;vesicle coat;1.23353150176885e-08!GO:0030662;coated vesicle membrane;1.23353150176885e-08!GO:0006163;purine nucleotide metabolic process;1.52106952270719e-08!GO:0009199;ribonucleoside triphosphate metabolic process;1.84112450087715e-08!GO:0006888;ER to Golgi vesicle-mediated transport;1.84123467334167e-08!GO:0005788;endoplasmic reticulum lumen;1.85326271378242e-08!GO:0016881;acid-amino acid ligase activity;1.94988023983578e-08!GO:0007049;cell cycle;2.12980214207451e-08!GO:0005524;ATP binding;2.66029395583442e-08!GO:0009152;purine ribonucleotide biosynthetic process;2.66553809677287e-08!GO:0009260;ribonucleotide biosynthetic process;2.76572367981289e-08!GO:0009141;nucleoside triphosphate metabolic process;2.99734910599941e-08!GO:0006461;protein complex assembly;3.14416845279701e-08!GO:0046933;hydrogen ion transporting ATP synthase activity, rotational mechanism;3.17080508265326e-08!GO:0017038;protein import;3.48335791505007e-08!GO:0009205;purine ribonucleoside triphosphate metabolic process;3.51916037946097e-08!GO:0009144;purine nucleoside triphosphate metabolic process;3.51916037946097e-08!GO:0003714;transcription corepressor activity;3.96664064882366e-08!GO:0016604;nuclear body;4.45937746751764e-08!GO:0006164;purine nucleotide biosynthetic process;4.50222079856703e-08!GO:0009142;nucleoside triphosphate biosynthetic process;4.78365950214253e-08!GO:0009201;ribonucleoside triphosphate biosynthetic process;4.78365950214253e-08!GO:0006366;transcription from RNA polymerase II promoter;4.78365950214253e-08!GO:0032559;adenyl ribonucleotide binding;6.10285621710399e-08!GO:0005768;endosome;6.84408801045676e-08!GO:0016564;transcription repressor activity;6.98853371337588e-08!GO:0015078;hydrogen ion transmembrane transporter activity;7.3131339385236e-08!GO:0009206;purine ribonucleoside triphosphate biosynthetic process;9.743099608712e-08!GO:0009145;purine nucleoside triphosphate biosynthetic process;9.743099608712e-08!GO:0015986;ATP synthesis coupled proton transport;1.00491272532333e-07!GO:0015985;energy coupled proton transport, down electrochemical gradient;1.00491272532333e-07!GO:0051246;regulation of protein metabolic process;1.00491272532333e-07!GO:0003924;GTPase activity;1.63613218092488e-07!GO:0005635;nuclear envelope;1.63613218092488e-07!GO:0030554;adenyl nucleotide binding;1.68707826392524e-07!GO:0031965;nuclear membrane;1.87803036713255e-07!GO:0009060;aerobic respiration;1.98750760309609e-07!GO:0019829;cation-transporting ATPase activity;2.18781785155666e-07!GO:0016887;ATPase activity;2.27625466588955e-07!GO:0048475;coated membrane;2.63064491780386e-07!GO:0030117;membrane coat;2.63064491780386e-07!GO:0042623;ATPase activity, coupled;3.70631520887488e-07!GO:0044453;nuclear membrane part;3.95845329761203e-07!GO:0046034;ATP metabolic process;3.95845329761203e-07!GO:0008361;regulation of cell size;4.61084642255573e-07!GO:0005798;Golgi-associated vesicle;5.09420559846839e-07!GO:0042254;ribosome biogenesis and assembly;6.40861255816404e-07!GO:0016049;cell growth;6.58370296917135e-07!GO:0045333;cellular respiration;7.4704090127832e-07!GO:0006754;ATP biosynthetic process;9.65561982386667e-07!GO:0006753;nucleoside phosphate metabolic process;9.65561982386667e-07!GO:0031324;negative regulation of cellular metabolic process;1.03967854117433e-06!GO:0009056;catabolic process;1.07896115682579e-06!GO:0050794;regulation of cellular process;1.25040011060103e-06!GO:0016876;ligase activity, forming aminoacyl-tRNA and related compounds;1.42419407109963e-06!GO:0004812;aminoacyl-tRNA ligase activity;1.42419407109963e-06!GO:0016875;ligase activity, forming carbon-oxygen bonds;1.42419407109963e-06!GO:0016607;nuclear speck;1.56449226327275e-06!GO:0000151;ubiquitin ligase complex;1.69913276419584e-06!GO:0030036;actin cytoskeleton organization and biogenesis;1.81134168659417e-06!GO:0006399;tRNA metabolic process;1.82945146854511e-06!GO:0051789;response to protein stimulus;1.90052833244458e-06!GO:0006986;response to unfolded protein;1.90052833244458e-06!GO:0016469;proton-transporting two-sector ATPase complex;1.98276844073352e-06!GO:0005773;vacuole;2.24393585643749e-06!GO:0000139;Golgi membrane;2.49783989129095e-06!GO:0043038;amino acid activation;2.51868094061622e-06!GO:0006418;tRNA aminoacylation for protein translation;2.51868094061622e-06!GO:0043039;tRNA aminoacylation;2.51868094061622e-06!GO:0043069;negative regulation of programmed cell death;2.97161463885032e-06!GO:0001558;regulation of cell growth;2.98416254424797e-06!GO:0032446;protein modification by small protein conjugation;3.47313802194447e-06!GO:0016567;protein ubiquitination;3.90659512138903e-06!GO:0005839;proteasome core complex (sensu Eukaryota);3.90659512138903e-06!GO:0031988;membrane-bound vesicle;3.95846580113456e-06!GO:0006974;response to DNA damage stimulus;3.99459192524388e-06!GO:0007005;mitochondrion organization and biogenesis;4.18759210128503e-06!GO:0016023;cytoplasmic membrane-bound vesicle;4.25031061629573e-06!GO:0015077;monovalent inorganic cation transmembrane transporter activity;4.4496326318743e-06!GO:0043067;regulation of programmed cell death;4.50903097094639e-06!GO:0042981;regulation of apoptosis;4.81268722913934e-06!GO:0043066;negative regulation of apoptosis;4.89692466282232e-06!GO:0051188;cofactor biosynthetic process;6.58407012517516e-06!GO:0006099;tricarboxylic acid cycle;7.1717880050978e-06!GO:0046356;acetyl-CoA catabolic process;7.1717880050978e-06!GO:0006793;phosphorus metabolic process;7.55675657263188e-06!GO:0006796;phosphate metabolic process;7.55675657263188e-06!GO:0016491;oxidoreductase activity;7.71086498646135e-06!GO:0030532;small nuclear ribonucleoprotein complex;8.85984309766721e-06!GO:0009109;coenzyme catabolic process;9.29627082550399e-06!GO:0051726;regulation of cell cycle;9.32380814261866e-06!GO:0045786;negative regulation of progression through cell cycle;9.37700340632316e-06!GO:0051170;nuclear import;9.53929463283553e-06!GO:0045259;proton-transporting ATP synthase complex;1.06046844257467e-05!GO:0009892;negative regulation of metabolic process;1.06366090170257e-05!GO:0022402;cell cycle process;1.08296092506001e-05!GO:0000074;regulation of progression through cell cycle;1.08765869545168e-05!GO:0006606;protein import into nucleus;1.14112802101034e-05!GO:0030029;actin filament-based process;1.14686777468251e-05!GO:0031252;leading edge;1.1892214344211e-05!GO:0065002;intracellular protein transport across a membrane;1.21183848644257e-05!GO:0006916;anti-apoptosis;1.3357781100786e-05!GO:0043123;positive regulation of I-kappaB kinase/NF-kappaB cascade;1.3760880367217e-05!GO:0051187;cofactor catabolic process;1.43314166262697e-05!GO:0055086;nucleobase, nucleoside and nucleotide metabolic process;1.49594957111007e-05!GO:0000323;lytic vacuole;1.52557175283163e-05!GO:0005764;lysosome;1.52557175283163e-05!GO:0006084;acetyl-CoA metabolic process;1.61060612848527e-05!GO:0006752;group transfer coenzyme metabolic process;1.69503954326893e-05!GO:0005667;transcription factor complex;1.9479350565664e-05!GO:0016310;phosphorylation;2.07035913777042e-05!GO:0008654;phospholipid biosynthetic process;2.11048387075969e-05!GO:0044440;endosomal part;2.2291103627616e-05!GO:0010008;endosome membrane;2.2291103627616e-05!GO:0005643;nuclear pore;2.24910017173022e-05!GO:0006325;establishment and/or maintenance of chromatin architecture;2.28709857865389e-05!GO:0004298;threonine endopeptidase activity;2.32493677944582e-05!GO:0006613;cotranslational protein targeting to membrane;2.43117553229961e-05!GO:0043122;regulation of I-kappaB kinase/NF-kappaB cascade;2.57810908755583e-05!GO:0031982;vesicle;2.67370723522357e-05!GO:0016787;hydrolase activity;2.75950429823346e-05!GO:0000245;spliceosome assembly;2.95861094778592e-05!GO:0005770;late endosome;3.03183533764326e-05!GO:0042625;ATPase activity, coupled to transmembrane movement of ions;3.06884699216339e-05!GO:0031410;cytoplasmic vesicle;3.49483313204879e-05!GO:0016591;DNA-directed RNA polymerase II, holoenzyme;4.39316335178435e-05!GO:0006323;DNA packaging;5.0658138493723e-05!GO:0015980;energy derivation by oxidation of organic compounds;5.17763847323023e-05!GO:0005525;GTP binding;6.04861895137885e-05!GO:0005762;mitochondrial large ribosomal subunit;6.69726430567571e-05!GO:0000315;organellar large ribosomal subunit;6.69726430567571e-05!GO:0045454;cell redox homeostasis;6.96178300467014e-05!GO:0009719;response to endogenous stimulus;7.15022698567185e-05!GO:0016481;negative regulation of transcription;7.18998598123592e-05!GO:0007249;I-kappaB kinase/NF-kappaB cascade;7.23367141186779e-05!GO:0045934;negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;7.2933945219983e-05!GO:0030867;rough endoplasmic reticulum membrane;7.48962706625936e-05!GO:0050789;regulation of biological process;7.53306273103233e-05!GO:0030133;transport vesicle;7.53306273103233e-05!GO:0009117;nucleotide metabolic process;9.10963132091415e-05!GO:0046930;pore complex;9.40718309170889e-05!GO:0043623;cellular protein complex assembly;0.000102339029451773!GO:0008092;cytoskeletal protein binding;0.000102944913054039!GO:0005905;coated pit;0.000103310316647254!GO:0004386;helicase activity;0.000106113218167016!GO:0008026;ATP-dependent helicase activity;0.000108966279471909!GO:0006091;generation of precursor metabolites and energy;0.000109115224815572!GO:0006281;DNA repair;0.000109328033326887!GO:0043566;structure-specific DNA binding;0.00011835635318587!GO:0040008;regulation of growth;0.000119437029412916!GO:0030663;COPI coated vesicle membrane;0.000119722003911041!GO:0030126;COPI vesicle coat;0.000119722003911041!GO:0016740;transferase activity;0.0001206413584028!GO:0033116;ER-Golgi intermediate compartment membrane;0.000121931831716819!GO:0007010;cytoskeleton organization and biogenesis;0.000135133443188038!GO:0009108;coenzyme biosynthetic process;0.00013946203722942!GO:0016853;isomerase activity;0.000162763084559012!GO:0019867;outer membrane;0.000208608304967596!GO:0003697;single-stranded DNA binding;0.00021255434514154!GO:0003755;peptidyl-prolyl cis-trans isomerase activity;0.000217746711143119!GO:0005769;early endosome;0.000227134394760652!GO:0005048;signal sequence binding;0.000235524332630196!GO:0044262;cellular carbohydrate metabolic process;0.000236160878973918!GO:0006357;regulation of transcription from RNA polymerase II promoter;0.000236411925610126!GO:0030137;COPI-coated vesicle;0.000255306721519891!GO:0016859;cis-trans isomerase activity;0.000258565095385548!GO:0015405;P-P-bond-hydrolysis-driven transmembrane transporter activity;0.000258565095385548!GO:0015399;primary active transmembrane transporter activity;0.000258565095385548!GO:0031202;RNA splicing factor activity, transesterification mechanism;0.0002675782478431!GO:0032561;guanyl ribonucleotide binding;0.000268530138182442!GO:0019001;guanyl nucleotide binding;0.000268530138182442!GO:0006403;RNA localization;0.000306898694052481!GO:0008250;oligosaccharyl transferase complex;0.000336928260913504!GO:0006612;protein targeting to membrane;0.000340643019260066!GO:0005885;Arp2/3 protein complex;0.000342696437419052!GO:0050657;nucleic acid transport;0.000377554314108194!GO:0051236;establishment of RNA localization;0.000377554314108194!GO:0050658;RNA transport;0.000377554314108194!GO:0003713;transcription coactivator activity;0.000377554314108194!GO:0016563;transcription activator activity;0.000382377393174157!GO:0031968;organelle outer membrane;0.000394233198687824!GO:0051276;chromosome organization and biogenesis;0.000394233198687824!GO:0006364;rRNA processing;0.000397049077209475!GO:0004576;oligosaccharyl transferase activity;0.000400296340425528!GO:0004579;dolichyl-diphosphooligosaccharide-protein glycotransferase activity;0.000417520538885737!GO:0016568;chromatin modification;0.000466198777335542!GO:0043021;ribonucleoprotein binding;0.000544826183569445!GO:0006891;intra-Golgi vesicle-mediated transport;0.000547428826970447!GO:0046474;glycerophospholipid biosynthetic process;0.000557260495854113!GO:0016072;rRNA metabolic process;0.000557260495854113!GO:0015630;microtubule cytoskeleton;0.000587020440658052!GO:0048522;positive regulation of cellular process;0.000614795347504553!GO:0000314;organellar small ribosomal subunit;0.000671635381681903!GO:0005763;mitochondrial small ribosomal subunit;0.000671635381681903!GO:0018196;peptidyl-asparagine modification;0.000784678116206532!GO:0018279;protein amino acid N-linked glycosylation via asparagine;0.000784678116206532!GO:0019899;enzyme binding;0.000800329314066663!GO:0007243;protein kinase cascade;0.000844477664573093!GO:0033178;proton-transporting two-sector ATPase complex, catalytic domain;0.000867878271808805!GO:0003724;RNA helicase activity;0.000881456835257528!GO:0000278;mitotic cell cycle;0.000935046995277728!GO:0005813;centrosome;0.00100585326598178!GO:0051427;hormone receptor binding;0.00100585326598178!GO:0016044;membrane organization and biogenesis;0.00113577716776398!GO:0005741;mitochondrial outer membrane;0.00120174347514415!GO:0045261;proton-transporting ATP synthase complex, catalytic core F(1);0.00122357249137045!GO:0004177;aminopeptidase activity;0.00122711933748722!GO:0005753;mitochondrial proton-transporting ATP synthase complex;0.00123951277433319!GO:0051920;peroxiredoxin activity;0.00131460636999941!GO:0031072;heat shock protein binding;0.00148268264532749!GO:0005583;fibrillar collagen;0.00149926715335275!GO:0030658;transport vesicle membrane;0.00150155978222877!GO:0043492;ATPase activity, coupled to movement of substances;0.00159078651236524!GO:0016197;endosome transport;0.00161594358324267!GO:0030132;clathrin coat of coated pit;0.00162677609990362!GO:0005815;microtubule organizing center;0.00165981390170698!GO:0065004;protein-DNA complex assembly;0.00172862140360833!GO:0035257;nuclear hormone receptor binding;0.00181116537562272!GO:0022890;inorganic cation transmembrane transporter activity;0.00188447535769399!GO:0016679;oxidoreductase activity, acting on diphenols and related substances as donors;0.00193270655580422!GO:0016681;oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor;0.00193270655580422!GO:0008121;ubiquinol-cytochrome-c reductase activity;0.00193270655580422!GO:0006839;mitochondrial transport;0.00199655603190157!GO:0044420;extracellular matrix part;0.00200313753193413!GO:0043284;biopolymer biosynthetic process;0.00202179406549415!GO:0042626;ATPase activity, coupled to transmembrane movement of substances;0.00202179406549415!GO:0030530;heterogeneous nuclear ribonucleoprotein complex;0.00207298116638858!GO:0045892;negative regulation of transcription, DNA-dependent;0.0021429032665159!GO:0016772;transferase activity, transferring phosphorus-containing groups;0.00255815589771563!GO:0043681;protein import into mitochondrion;0.00261105233336749!GO:0006650;glycerophospholipid metabolic process;0.00266346516165416!GO:0005852;eukaryotic translation initiation factor 3 complex;0.00267923713421444!GO:0005838;proteasome regulatory particle (sensu Eukaryota);0.00267923713421444!GO:0006333;chromatin assembly or disassembly;0.00281274712957004!GO:0046489;phosphoinositide biosynthetic process;0.00282090751053426!GO:0016820;hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances;0.00287959807920176!GO:0019222;regulation of metabolic process;0.00288535230323106!GO:0003729;mRNA binding;0.00293034522683092!GO:0007006;mitochondrial membrane organization and biogenesis;0.00300641631809991!GO:0005791;rough endoplasmic reticulum;0.00311651661655356!GO:0048500;signal recognition particle;0.00322424932035211!GO:0005581;collagen;0.00325103880946744!GO:0006892;post-Golgi vesicle-mediated transport;0.00334209528593211!GO:0051252;regulation of RNA metabolic process;0.00352806889617043!GO:0006260;DNA replication;0.00356623437637861!GO:0019843;rRNA binding;0.00358412924951921!GO:0016281;eukaryotic translation initiation factor 4F complex;0.00358666174534999!GO:0007050;cell cycle arrest;0.00372751448397417!GO:0016676;oxidoreductase activity, acting on heme group of donors, oxygen as acceptor;0.0037328521658387!GO:0015002;heme-copper terminal oxidase activity;0.0037328521658387!GO:0016675;oxidoreductase activity, acting on heme group of donors;0.0037328521658387!GO:0004129;cytochrome-c oxidase activity;0.0037328521658387!GO:0015931;nucleobase, nucleoside, nucleotide and nucleic acid transport;0.00380583591210688!GO:0030176;integral to endoplasmic reticulum membrane;0.0038473828287458!GO:0045045;secretory pathway;0.00387820396288028!GO:0051128;regulation of cellular component organization and biogenesis;0.00395849625787944!GO:0030134;ER to Golgi transport vesicle;0.00399199251261351!GO:0030027;lamellipodium;0.00399199251261351!GO:0048471;perinuclear region of cytoplasm;0.00420613973630501!GO:0051028;mRNA transport;0.00420613973630501!GO:0030660;Golgi-associated vesicle membrane;0.00425518347479178!GO:0003779;actin binding;0.00433164254122957!GO:0046467;membrane lipid biosynthetic process;0.00510671886117087!GO:0030127;COPII vesicle coat;0.00514433400660061!GO:0012507;ER to Golgi transport vesicle membrane;0.00514433400660061!GO:0051168;nuclear export;0.00515169791993321!GO:0017166;vinculin binding;0.00521352143620688!GO:0003899;DNA-directed RNA polymerase activity;0.00521352143620688!GO:0016765;transferase activity, transferring alkyl or aryl (other than methyl) groups;0.00539027361032175!GO:0006497;protein amino acid lipidation;0.0053916264104657!GO:0009967;positive regulation of signal transduction;0.00599038091436388!GO:0015992;proton transport;0.00612275507622317!GO:0016779;nucleotidyltransferase activity;0.00642844603616949!GO:0045792;negative regulation of cell size;0.00648400179258721!GO:0048468;cell development;0.00649350182757695!GO:0065007;biological regulation;0.00651195285690212!GO:0005869;dynactin complex;0.00655180167462025!GO:0006818;hydrogen transport;0.0066424498313027!GO:0048487;beta-tubulin binding;0.00668647085016629!GO:0006890;retrograde vesicle-mediated transport, Golgi to ER;0.00671704863804292!GO:0007179;transforming growth factor beta receptor signaling pathway;0.00688211206325176!GO:0006414;translational elongation;0.00699194110460813!GO:0008154;actin polymerization and/or depolymerization;0.00701890253560419!GO:0030659;cytoplasmic vesicle membrane;0.00707206580994735!GO:0006614;SRP-dependent cotranslational protein targeting to membrane;0.00707206580994735!GO:0045047;protein targeting to ER;0.00707206580994735!GO:0030308;negative regulation of cell growth;0.00712141789852384!GO:0017015;regulation of transforming growth factor beta receptor signaling pathway;0.00712823132031976!GO:0007264;small GTPase mediated signal transduction;0.0072122836122611!GO:0019752;carboxylic acid metabolic process;0.00721826753156656!GO:0003746;translation elongation factor activity;0.00735488311727584!GO:0006082;organic acid metabolic process;0.00744576964592182!GO:0006383;transcription from RNA polymerase III promoter;0.00748973524692525!GO:0008186;RNA-dependent ATPase activity;0.00748973524692525!GO:0065009;regulation of a molecular function;0.00751273260138411!GO:0006626;protein targeting to mitochondrion;0.00754196713207909!GO:0007178;transmembrane receptor protein serine/threonine kinase signaling pathway;0.00755510573747175!GO:0006509;membrane protein ectodomain proteolysis;0.00755510573747175!GO:0033619;membrane protein proteolysis;0.00755510573747175!GO:0008139;nuclear localization sequence binding;0.00756969515957435!GO:0031901;early endosome membrane;0.00826237750801764!GO:0051287;NAD binding;0.00885318455408351!GO:0051087;chaperone binding;0.00905796137658193!GO:0005786;signal recognition particle, endoplasmic reticulum targeting;0.00908640383008489!GO:0000287;magnesium ion binding;0.0091739324011429!GO:0000059;protein import into nucleus, docking;0.00968153187696458!GO:0030118;clathrin coat;0.00982204720601704!GO:0016862;intramolecular oxidoreductase activity, interconverting keto- and enol-groups;0.00987094299139608!GO:0030521;androgen receptor signaling pathway;0.00987154660976667!GO:0051329;interphase of mitotic cell cycle;0.00993686451246262!GO:0005801;cis-Golgi network;0.0102394088945585!GO:0045263;proton-transporting ATP synthase complex, coupling factor F(o);0.0103475718250536!GO:0033177;proton-transporting two-sector ATPase complex, proton-transporting domain;0.0103475718250536!GO:0051325;interphase;0.0103965815094711!GO:0007030;Golgi organization and biogenesis;0.0105272698664878!GO:0030880;RNA polymerase complex;0.0105272698664878!GO:0009165;nucleotide biosynthetic process;0.0107774953681747!GO:0051045;negative regulation of membrane protein ectodomain proteolysis;0.011049551279061!GO:0051043;regulation of membrane protein ectodomain proteolysis;0.011049551279061!GO:0043488;regulation of mRNA stability;0.0111950455094647!GO:0043487;regulation of RNA stability;0.0111950455094647!GO:0030833;regulation of actin filament polymerization;0.0114009460708081!GO:0007160;cell-matrix adhesion;0.0114406013895275!GO:0016706;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors;0.0117296306972947!GO:0007040;lysosome organization and biogenesis;0.0118857088198785!GO:0031589;cell-substrate adhesion;0.0119589513091035!GO:0000049;tRNA binding;0.0120277205597995!GO:0001726;ruffle;0.0121051083320086!GO:0015631;tubulin binding;0.0124726276435324!GO:0016780;phosphotransferase activity, for other substituted phosphate groups;0.0127613976127111!GO:0031543;peptidyl-proline dioxygenase activity;0.0127872321608114!GO:0001527;microfibril;0.012942846630965!GO:0008312;7S RNA binding;0.0130363998793339!GO:0008243;plasminogen activator activity;0.0134188565961866!GO:0006607;NLS-bearing substrate import into nucleus;0.013434333163531!GO:0030041;actin filament polymerization;0.0136558906414784!GO:0006595;polyamine metabolic process;0.0138757994678831!GO:0008022;protein C-terminus binding;0.0141026625371427!GO:0051493;regulation of cytoskeleton organization and biogenesis;0.0142198079447224!GO:0033043;regulation of organelle organization and biogenesis;0.0142198079447224!GO:0000785;chromatin;0.0143322636446638!GO:0044433;cytoplasmic vesicle part;0.0147911572435009!GO:0003690;double-stranded DNA binding;0.014864661446351!GO:0008064;regulation of actin polymerization and/or depolymerization;0.0150781622177521!GO:0003711;transcription elongation regulator activity;0.0150817649069856!GO:0030145;manganese ion binding;0.0152218421500992!GO:0045935;positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process;0.015618492386592!GO:0030384;phosphoinositide metabolic process;0.0158624488413542!GO:0006354;RNA elongation;0.0161641804145179!GO:0048518;positive regulation of biological process;0.0161641804145179!GO:0035258;steroid hormone receptor binding;0.0164734913955974!GO:0008610;lipid biosynthetic process;0.0165293339724133!GO:0006402;mRNA catabolic process;0.0167175983437743!GO:0048144;fibroblast proliferation;0.0170915509172493!GO:0048145;regulation of fibroblast proliferation;0.0170915509172493!GO:0006984;ER-nuclear signaling pathway;0.0171189950596314!GO:0042158;lipoprotein biosynthetic process;0.0171452558635887!GO:0046483;heterocycle metabolic process;0.0171834265621621!GO:0004004;ATP-dependent RNA helicase activity;0.0171891415265837!GO:0030125;clathrin vesicle coat;0.0174142280259862!GO:0030665;clathrin coated vesicle membrane;0.0174142280259862!GO:0045936;negative regulation of phosphate metabolic process;0.0177507540918202!GO:0016667;oxidoreductase activity, acting on sulfur group of donors;0.0179093252845191!GO:0016363;nuclear matrix;0.0180301221245132!GO:0055029;nuclear DNA-directed RNA polymerase complex;0.0187025104929546!GO:0000428;DNA-directed RNA polymerase complex;0.0187025104929546!GO:0045926;negative regulation of growth;0.0189801662532115!GO:0031529;ruffle organization and biogenesis;0.0190511069021819!GO:0006506;GPI anchor biosynthetic process;0.0195990672029923!GO:0043022;ribosome binding;0.0200054957159996!GO:0005694;chromosome;0.0202783694313821!GO:0006979;response to oxidative stress;0.0209097942832424!GO:0050811;GABA receptor binding;0.0211293425233313!GO:0045941;positive regulation of transcription;0.0212040304107473!GO:0016272;prefoldin complex;0.0212040304107473!GO:0031418;L-ascorbic acid binding;0.0214775549952065!GO:0000339;RNA cap binding;0.0217605922588695!GO:0007034;vacuolar transport;0.021821018344228!GO:0006505;GPI anchor metabolic process;0.0219013475529155!GO:0000122;negative regulation of transcription from RNA polymerase II promoter;0.0221575134657215!GO:0006334;nucleosome assembly;0.0221866455338429!GO:0048146;positive regulation of fibroblast proliferation;0.0222943747128246!GO:0019798;procollagen-proline dioxygenase activity;0.0222981493079709!GO:0005520;insulin-like growth factor binding;0.0225740288200834!GO:0000209;protein polyubiquitination;0.0226733749991162!GO:0007033;vacuole organization and biogenesis;0.0228801856251818!GO:0012506;vesicle membrane;0.022884070314129!GO:0008047;enzyme activator activity;0.0233168287372038!GO:0032940;secretion by cell;0.0238727034942898!GO:0005862;muscle thin filament tropomyosin;0.024124680262685!GO:0045893;positive regulation of transcription, DNA-dependent;0.0244065244613099!GO:0008180;signalosome;0.0253020659609279!GO:0000082;G1/S transition of mitotic cell cycle;0.0255188249220353!GO:0005665;DNA-directed RNA polymerase II, core complex;0.0255188249220353!GO:0050681;androgen receptor binding;0.0256507070197109!GO:0031124;mRNA 3'-end processing;0.0260177845834188!GO:0006740;NADPH regeneration;0.0273427041910048!GO:0006098;pentose-phosphate shunt;0.0273427041910048!GO:0005595;collagen type XII;0.027394414672688!GO:0008147;structural constituent of bone;0.0278027089547615!GO:0031497;chromatin assembly;0.0278027089547615!GO:0035035;histone acetyltransferase binding;0.0282983706795661!GO:0005586;collagen type III;0.0284564699707542!GO:0030518;steroid hormone receptor signaling pathway;0.0293376602334382!GO:0016126;sterol biosynthetic process;0.0293376602334382!GO:0030032;lamellipodium biogenesis;0.0297037575137226!GO:0043433;negative regulation of transcription factor activity;0.0309599818443302!GO:0006289;nucleotide-excision repair;0.0313452999182209!GO:0031902;late endosome membrane;0.0314626401057231!GO:0005684;U2-dependent spliceosome;0.0315135444585826!GO:0008287;protein serine/threonine phosphatase complex;0.03152971504078!GO:0008632;apoptotic program;0.0316500036182999!GO:0031272;regulation of pseudopodium formation;0.0316500036182999!GO:0031269;pseudopodium formation;0.0316500036182999!GO:0031344;regulation of cell projection organization and biogenesis;0.0316500036182999!GO:0031268;pseudopodium organization and biogenesis;0.0316500036182999!GO:0031346;positive regulation of cell projection organization and biogenesis;0.0316500036182999!GO:0031274;positive regulation of pseudopodium formation;0.0316500036182999!GO:0003756;protein disulfide isomerase activity;0.0317946793087943!GO:0016864;intramolecular oxidoreductase activity, transposing S-S bonds;0.0317946793087943!GO:0018193;peptidyl-amino acid modification;0.032393524968409!GO:0000307;cyclin-dependent protein kinase holoenzyme complex;0.0335226527184166!GO:0006417;regulation of translation;0.0335551638619512!GO:0030433;ER-associated protein catabolic process;0.0342056159800694!GO:0006515;misfolded or incompletely synthesized protein catabolic process;0.0342056159800694!GO:0031625;ubiquitin protein ligase binding;0.0342746814363846!GO:0031371;ubiquitin conjugating enzyme complex;0.0343155095714225!GO:0004287;prolyl oligopeptidase activity;0.0343155095714225!GO:0042326;negative regulation of phosphorylation;0.0346422808889191!GO:0022408;negative regulation of cell-cell adhesion;0.0349725489323379!GO:0006611;protein export from nucleus;0.035242963221274!GO:0033673;negative regulation of kinase activity;0.0366520342533158!GO:0006469;negative regulation of protein kinase activity;0.0366520342533158!GO:0005774;vacuolar membrane;0.0370351284101736!GO:0004656;procollagen-proline 4-dioxygenase activity;0.0372050486132948!GO:0031545;peptidyl-proline 4-dioxygenase activity;0.0372050486132948!GO:0007265;Ras protein signal transduction;0.0379977498403929!GO:0007021;tubulin folding;0.0380659195993433!GO:0005637;nuclear inner membrane;0.0382155725063856!GO:0042802;identical protein binding;0.0383669359532747!GO:0005832;chaperonin-containing T-complex;0.0387926508966344!GO:0000118;histone deacetylase complex;0.0392058405580004!GO:0007041;lysosomal transport;0.0395234815948919!GO:0008475;procollagen-lysine 5-dioxygenase activity;0.0401608757998648!GO:0030865;cortical cytoskeleton organization and biogenesis;0.0404878052377039!GO:0004674;protein serine/threonine kinase activity;0.0410259149210983!GO:0044427;chromosomal part;0.0410259149210983!GO:0030911;TPR domain binding;0.0411001730271304!GO:0000902;cell morphogenesis;0.0411001730271304!GO:0032989;cellular structure morphogenesis;0.0411001730271304!GO:0051101;regulation of DNA binding;0.0413425833777789!GO:0001872;zymosan binding;0.0413425833777789!GO:0001878;response to yeast;0.0413425833777789!GO:0003923;GPI-anchor transamidase activity;0.0420507470404205!GO:0016255;attachment of GPI anchor to protein;0.0420507470404205!GO:0042765;GPI-anchor transamidase complex;0.0420507470404205!GO:0006401;RNA catabolic process;0.0432635582458564!GO:0008234;cysteine-type peptidase activity;0.0432635582458564!GO:0030508;thiol-disulfide exchange intermediate activity;0.0432635582458564!GO:0030119;AP-type membrane coat adaptor complex;0.0432635582458564!GO:0006897;endocytosis;0.0434922620411322!GO:0010324;membrane invagination;0.0434922620411322!GO:0046519;sphingoid metabolic process;0.0441744029208403!GO:0051098;regulation of binding;0.0448443534032704!GO:0006518;peptide metabolic process;0.0450324265770213!GO:0045639;positive regulation of myeloid cell differentiation;0.0453294406351576!GO:0006007;glucose catabolic process;0.0463098256614938!GO:0008601;protein phosphatase type 2A regulator activity;0.0464384966359929!GO:0051348;negative regulation of transferase activity;0.0477904217649907!GO:0051301;cell division;0.0489284136292614!GO:0016584;nucleosome positioning;0.0494806162826479 | |||
|sample_id=10705 | |sample_id=10705 | ||
|sample_note= | |sample_note= |
Revision as of 18:12, 25 June 2012
Name: | Ewing's sarcoma cell line:Hs 863.T |
---|---|
Species: | Human (Homo sapiens) |
Library ID: | {{{library_id}}} |
Sample type: | {{{sample_category}}} |
Genomic View: | UCSC |
CAGEd-oPOSSUM: | link |
Additional information | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sample information
RNA information
|
Download raw sequence, BAM & CTSS | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Relative expression to median (log10)
Transcription factors with enriched expression in this sampleRanked list of transcription factor promoter expression in this sample relative to the median expression in the FANTOM5 collection is shown. Value is log10 transformed.
Co-expression clusters with enriched expression in this sampleRanked list of co-expression cluster expression in this sample relative to the median expression in the FANTOM5 collection is shown. Value is log10 transformed. <br>Analyst:NA <br><br>link to dataset.<br>data
Repeat families with enriched expression in this sample<b>Summary:</b>Ranked list of repeat family expression in this sample relative tothe median expression in the FANTOM5 collection is shown. Value is log10transformed.<br><b>Analyst:</b>NA<br><br>link to dataset.<br>data
no result for this sample
TFBS(DNA)motifs over-represented in proximal region of promoters active in this sample
JASPAR motifs<b>Summary:</b>Association of JASPAR motif to the promoter expression in thissample. Pearson's correlation between the number of TFBSs estimated byusing the position-weight matrix for each promoter and its expression isexpressed as Z-score by taking the ones based on random position-weightmatrix, and the tail probability of the normal distribution correspondingto the Z-score is taken as the resulting P-value. Lower P-value indicatesmore (non-random) association of the motif to promoter expression<br><b>Analyst:</b> Michiel de Hoon <br><br><br>link to dataset.<br>data
library id: CNhs11836
FANTOM5 phase1 novel unique motifs<b>Summary:</b>Association of the 169 novel and unique motifs discovered in FANTOM5 phase1 in this sample. Among the de-novo motifs discovered by DMF, HOMER,ChIPMunk, and ScanAll, only novel motifs are selected after comparison with known motif sets, and their clustering based on MACRO-APE resulted in169 novel and unique motifs. Their association to the promoter expression is evaluated in the same way to the JASPAR motif above<br><b>Analyst:</b> Michiel de Hoon <br><br><br>link to dataset.<br>data
library id: CNhs11836
Novel motif | Logo | P-value |
---|---|---|
1 | 1 | 0.316 |
10 | 10 | 0.384 |
100 | 100 | 0.921 |
101 | 101 | 0.902 |
102 | 102 | 0.618 |
103 | 103 | 0.302 |
104 | 104 | 0.602 |
105 | 105 | 0.198 |
106 | 106 | 0.0324 |
107 | 107 | 0.0155 |
108 | 108 | 0.195 |
109 | 109 | 0.683 |
11 | 11 | 0.365 |
110 | 110 | 0.76 |
111 | 111 | 0.345 |
112 | 112 | 0.222 |
113 | 113 | 0.146 |
114 | 114 | 0.107 |
115 | 115 | 0.155 |
116 | 116 | 0.0458 |
117 | 117 | 0.951 |
118 | 118 | 0.893 |
119 | 119 | 0.149 |
12 | 12 | 0.221 |
120 | 120 | 0.788 |
121 | 121 | 0.895 |
122 | 122 | 0.0968 |
123 | 123 | 0.375 |
124 | 124 | 0.612 |
125 | 125 | 0.55 |
126 | 126 | 0.978 |
127 | 127 | 0.897 |
128 | 128 | 0.0886 |
129 | 129 | 0.864 |
13 | 13 | 0.909 |
130 | 130 | 0.193 |
131 | 131 | 0.821 |
132 | 132 | 0.24 |
133 | 133 | 0.956 |
134 | 134 | 0.813 |
135 | 135 | 0.744 |
136 | 136 | 0.447 |
137 | 137 | 0.462 |
138 | 138 | 0.776 |
139 | 139 | 0.0382 |
14 | 14 | 0.309 |
140 | 140 | 0.412 |
141 | 141 | 0.78 |
142 | 142 | 0.809 |
143 | 143 | 0.685 |
144 | 144 | 0.339 |
145 | 145 | 0.467 |
146 | 146 | 0.42 |
147 | 147 | 0.151 |
148 | 148 | 0.353 |
149 | 149 | 0.00485 |
15 | 15 | 0.729 |
150 | 150 | 0.174 |
151 | 151 | 0.659 |
152 | 152 | 0.0218 |
153 | 153 | 0.242 |
154 | 154 | 0.207 |
155 | 155 | 0.229 |
156 | 156 | 0.443 |
157 | 157 | 0.365 |
158 | 158 | 0.0524 |
159 | 159 | 0.305 |
16 | 16 | 0.0178 |
160 | 160 | 0.87 |
161 | 161 | 0.495 |
162 | 162 | 0.326 |
163 | 163 | 0.851 |
164 | 164 | 0.0159 |
165 | 165 | 0.695 |
166 | 166 | 0.0433 |
167 | 167 | 0.615 |
168 | 168 | 0.236 |
169 | 169 | 0.0203 |
17 | 17 | 0.164 |
18 | 18 | 0.0449 |
19 | 19 | 0.0039 |
2 | 2 | 0.432 |
20 | 20 | 0.974 |
21 | 21 | 0.266 |
22 | 22 | 0.405 |
23 | 23 | 0.0899 |
24 | 24 | 0.345 |
25 | 25 | 0.517 |
26 | 26 | 0.272 |
27 | 27 | 0.872 |
28 | 28 | 0.647 |
29 | 29 | 0.375 |
3 | 3 | 0.373 |
30 | 30 | 0.966 |
31 | 31 | 0.448 |
32 | 32 | 2.42994e-17 |
33 | 33 | 0.965 |
34 | 34 | 0.925 |
35 | 35 | 0.844 |
36 | 36 | 0.0697 |
37 | 37 | 0.126 |
38 | 38 | 0.591 |
39 | 39 | 0.301 |
4 | 4 | 0.74 |
40 | 40 | 0.212 |
41 | 41 | 0.973 |
42 | 42 | 0.709 |
43 | 43 | 0.23 |
44 | 44 | 0.312 |
45 | 45 | 0.952 |
46 | 46 | 0.15 |
47 | 47 | 0.971 |
48 | 48 | 0.936 |
49 | 49 | 0.384 |
5 | 5 | 0.21 |
50 | 50 | 0.57 |
51 | 51 | 0.848 |
52 | 52 | 0.578 |
53 | 53 | 0.548 |
54 | 54 | 0.545 |
55 | 55 | 0.0313 |
56 | 56 | 0.852 |
57 | 57 | 0.287 |
58 | 58 | 0.791 |
59 | 59 | 0.12 |
6 | 6 | 0.522 |
60 | 60 | 0.506 |
61 | 61 | 0.342 |
62 | 62 | 0.397 |
63 | 63 | 0.131 |
64 | 64 | 0.906 |
65 | 65 | 0.394 |
66 | 66 | 0.183 |
67 | 67 | 0.565 |
68 | 68 | 0.968 |
69 | 69 | 0.397 |
7 | 7 | 0.437 |
70 | 70 | 0.062 |
71 | 71 | 0.185 |
72 | 72 | 0.934 |
73 | 73 | 0.0115 |
74 | 74 | 0.383 |
75 | 75 | 0.466 |
76 | 76 | 0.726 |
77 | 77 | 0.0454 |
78 | 78 | 0.977 |
79 | 79 | 0.00188 |
8 | 8 | 0.0321 |
80 | 80 | 0.548 |
81 | 81 | 0.36 |
82 | 82 | 0.0601 |
83 | 83 | 0.888 |
84 | 84 | 0.643 |
85 | 85 | 0.0257 |
86 | 86 | 0.725 |
87 | 87 | 0.643 |
88 | 88 | 0.568 |
89 | 89 | 0.211 |
9 | 9 | 0.746 |
90 | 90 | 0.331 |
91 | 91 | 0.541 |
92 | 92 | 0.031 |
93 | 93 | 0.963 |
94 | 94 | 0.334 |
95 | 95 | 0.54 |
96 | 96 | 0.333 |
97 | 97 | 0.475 |
98 | 98 | 0.613 |
99 | 99 | 0.0735 |
de novo motifs identified by HOMER in promoters active in this sample<b>Summary:</b>The result of HOMER in this sample is shown.<br><b>Analyst:</b>NA <br>
library id: CNhs11836
FANTOM5 (FF) ontology
Direct parent terms
is_a relathionship
DOID:3369 peripheral primitive neuroectodermal tumor
EFO:0002091 biological replicate
FF:0000003 cell line sample
FF:0000210 human sample
FF:0104201 Ewing's sarcoma cell line sample
Ancestor terms (non development)<b>Summary:</b>Connected ontology terms with is_a, part_of or located_in relationship <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source data<br>data
DOID: Disease
4 (disease)
0050686 (organ system cancer)
162 (cancer)
14566 (disease of cellular proliferation)
3093 (nervous system cancer)
0050687 (cell type cancer)
1192 (peripheral nervous system neoplasm)
1115 (sarcoma)
3369 (peripheral primitive neuroectodermal tumor)
UBERON: Anatomy
0002384 (connective tissue)
0000479 (tissue)
0000061 (anatomical structure)
0000465 (material anatomical entity)
0001062 (anatomical entity)
FF: FANTOM5
NA
Ancestor terms (development)<b>Summary:</b>Connected ontology terms with develops_from, derives_from or preceded_by relationship <br><b>Analyst:</b> Hideya Kawaji <br><br>link to source data<br>data
NA